Peter Honig - May 24, 2023 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
Director
Signature
/s/ Nancy Smith, Attorney-in-Fact for Peter Honig
Stock symbol
KPTI
Transactions as of
May 24, 2023
Transactions value $
$0
Form type
4
Date filed
5/25/2023, 04:06 PM
Previous filing
Jun 24, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KPTI Nonstatutory Stock Option (right to buy) Award $0 +34K $0.00 34K May 24, 2023 Common Stock 34K $2.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests as to 100% of the underlying shares on May 24, 2024.